These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20711835)
1. Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Yu HR; Kuo HC; Huang EY; Liang CD; Hwang KP; Lin IC; Sheen JM; Wang TJ; Wang CL; Yang KD Pediatr Cardiol; 2010 Nov; 31(8):1151-6. PubMed ID: 20711835 [TBL] [Abstract][Full Text] [Related]
2. Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease. Ou-Yang MC; Kuo HC; Lin IC; Sheen JM; Huang FC; Chen CC; Huang YH; Lin YJ; Yu HR ScientificWorldJournal; 2013; 2013():382523. PubMed ID: 23956692 [TBL] [Abstract][Full Text] [Related]
3. Plasma H2S predicts coronary artery lesions in children with Kawasaki disease. Sun Y; Yuan Y; Yan H; Wan H; Li X; Chen S; Li H; Tang C; Du J; Liu G; Jin H Pediatr Int; 2015 Oct; 57(5):840-4. PubMed ID: 25808254 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study. Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704 [TBL] [Abstract][Full Text] [Related]
5. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease. Wang N; Gao Y; Wang Y; Dai Y; Tang Y; Huang J; Sun L; Qian G; Ma J; Li X; Liu Y; Yang D; Huang X; Wang W; Li W; Zhuo W; Lv H; Liu Z Int Immunopharmacol; 2024 Sep; 139():112698. PubMed ID: 39029232 [TBL] [Abstract][Full Text] [Related]
6. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease]. Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301 [TBL] [Abstract][Full Text] [Related]
7. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease. Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T Front Immunol; 2021; 12():624802. PubMed ID: 33912155 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients. Dai L; Zhang L; He J; Huang R; Tang W; Guo H; Shang X Ital J Pediatr; 2024 Oct; 50(1):209. PubMed ID: 39385218 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease. Chang LS; Lin YJ; Yan JH; Guo MM; Lo MH; Kuo HC BMC Pediatr; 2020 Aug; 20(1):398. PubMed ID: 32838756 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease. Lu Y; Guo Y; Si F; Chen T; Jin M; Wen Y; Wang X Sci Rep; 2020 Jun; 10(1):10211. PubMed ID: 32576944 [TBL] [Abstract][Full Text] [Related]
11. Overweight, obesity and coronary artery lesions among Kawasaki disease patients. Shi H; Weng F; Li C; Jin Z; Hu J; Chu M; Qiu H Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1604-1612. PubMed ID: 33812731 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510 [TBL] [Abstract][Full Text] [Related]
13. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide]. Huiling L; Yaping L; Xiufen H Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507 [TBL] [Abstract][Full Text] [Related]
14. [Changes of P-selectin and E-selectin in children with Kawasaki disease]. Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793 [TBL] [Abstract][Full Text] [Related]
16. Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease. Song RX; Zou QM; Li XH; Xu NP; Zhang T; Fu J; Cui XD Pediatr Res; 2016 Feb; 79(2):301-7. PubMed ID: 26536449 [TBL] [Abstract][Full Text] [Related]
17. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Yu HR; Kuo HC; Sheen JM; Wang L; Lin IC; Wang CL; Yang KD Pediatr Allergy Immunol; 2009 Nov; 20(7):699-707. PubMed ID: 19170925 [TBL] [Abstract][Full Text] [Related]
18. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease. Bai B; Ya JL; Yan C J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129 [TBL] [Abstract][Full Text] [Related]
19. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease. Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160 [TBL] [Abstract][Full Text] [Related]
20. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]